ADMA BIOLOGICS, INC. Annual Operating Lease, Payments in USD from 2020 to 2023

Taxonomy & unit
us-gaap: USD
Description
Amount of cash outflow from operating lease, excluding payments to bring another asset to condition and location necessary for its intended use.
Summary
Adma Biologics, Inc. quarterly/annual Operating Lease, Payments history and growth rate from 2020 to 2023.
  • Adma Biologics, Inc. Operating Lease, Payments for the quarter ending September 30, 2024 was $600K, unchanged year-over-year.
  • Adma Biologics, Inc. Operating Lease, Payments for the twelve months ending September 30, 2024 was $2.4M, a 4.35% increase year-over-year.
  • Adma Biologics, Inc. annual Operating Lease, Payments for 2023 was $2.4M, a 33.3% increase from 2022.
  • Adma Biologics, Inc. annual Operating Lease, Payments for 2022 was $1.8M, a 28.6% increase from 2021.
  • Adma Biologics, Inc. annual Operating Lease, Payments for 2021 was $1.4M, a 180% increase from 2020.
Operating Lease, Payments, Trailing 12 Months (USD)
Operating Lease, Payments, Annual (USD)
Operating Lease, Payments, YoY Annual Growth (%)
Period Value YoY Chg Change % Start Date End Date Report Filed
2023 $2.4M +$600K +33.3% Jan 1, 2023 Dec 31, 2023 10-K 2024-02-28
2022 $1.8M +$400K +28.6% Jan 1, 2022 Dec 31, 2022 10-K 2024-02-28
2021 $1.4M +$900K +180% Jan 1, 2021 Dec 31, 2021 10-K 2024-02-28
2020 $500K Jan 1, 2020 Dec 31, 2020 10-K 2022-03-24
* An asterisk sign (*) next to the value indicates that the value is likely invalid.